{"url_path":"/sec/krys/8-k/2026-07-21/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-21","source_url":"https://www.sec.gov/Archives/edgar/data/1711279/0001711279-26-000050-index.html","accession_number":"0001711279-26-000050","cik":"0001711279","ticker":"KRYS","issuer_name":"Krystal Biotech, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1711279/0001711279-26-000050-index.html","primary_entity_key":"0001711279","primary_entity_name":"Krystal Biotech, Inc."},"word_count":88,"has_tables":true,"body_markdown":"Item 9.01    Financial Statements and Exhibits.\n\n(d)    Exhibits.\n\nExhibit\nNo.  Description\n\n99.1\n[Image of corneal epithelial defect closure from patent prosecution record (furnished herewith)](image.htm)\n\n104Cover Page Interactive Data file (embedded within the Inline XBRL document)\n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\nDate: July 21, 2026\n  KRYSTAL BIOTECH, INC.\n\n  By: /s/ Krish S. Krishnan\n\n  Name: Krish S. Krishnan\n\n  Title: Chairman and Chief Executive Officer"}